icad inc (ICAD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, icad inc (ICAD) has a cash flow conversion efficiency ratio of 0.002x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($60.00K) by net assets ($30.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ICAD cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
icad inc - Cash Flow Conversion Efficiency Trend (1988–2024)
This chart illustrates how icad inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
icad inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of icad inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atlas Lithium Corporation Common Stock
NASDAQ:ATLX
|
-0.202x |
|
Whanin Pharm
KO:016580
|
0.006x |
|
Yibitas Yozgat Isci Birligi Insaat Malzemeleri Ticaret Sanayi AS
IS:YBTAS
|
0.079x |
|
Bogota Financial Corp
NASDAQ:BSBK
|
0.002x |
|
Havila Kystruten AS
OL:HKY
|
-0.034x |
|
Lhyfe SA
PA:LHYFE
|
-0.190x |
|
Spyrosoft Spólka Akcyjna
F:2NP
|
0.126x |
|
Peter Warren Automotive Holdings Ltd
AU:PWR
|
0.106x |
Annual Cash Flow Conversion Efficiency for icad inc (1988–2024)
The table below shows the annual cash flow conversion efficiency of icad inc from 1988 to 2024. For the full company profile with market capitalisation and key ratios, see icad inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $28.68 Million | $-3.94 Million | -0.138x | +7.41% |
| 2023-12-31 | $33.42 Million | $-4.96 Million | -0.149x | +59.46% |
| 2022-12-31 | $34.90 Million | $-12.79 Million | -0.366x | -81.18% |
| 2021-12-31 | $46.52 Million | $-9.41 Million | -0.202x | +11.62% |
| 2020-12-31 | $30.52 Million | $-6.99 Million | -0.229x | +83.67% |
| 2019-12-31 | $5.07 Million | $-7.11 Million | -1.401x | -149.93% |
| 2018-12-31 | $6.90 Million | $-3.87 Million | -0.561x | -9.11% |
| 2017-12-31 | $14.28 Million | $-7.34 Million | -0.514x | -134.90% |
| 2016-12-31 | $25.04 Million | $-5.48 Million | -0.219x | -277.07% |
| 2015-12-31 | $32.75 Million | $-1.90 Million | -0.058x | -213.69% |
| 2014-12-31 | $62.78 Million | $3.20 Million | 0.051x | +176.62% |
| 2013-12-31 | $21.38 Million | $-1.42 Million | -0.067x | +56.16% |
| 2012-12-31 | $27.66 Million | $-4.20 Million | -0.152x | +45.98% |
| 2011-12-31 | $36.05 Million | $-10.14 Million | -0.281x | -10032.78% |
| 2010-12-31 | $73.21 Million | $207.33K | 0.003x | -94.55% |
| 2009-12-31 | $66.31 Million | $3.44 Million | 0.052x | -64.80% |
| 2008-12-31 | $66.29 Million | $9.78 Million | 0.147x | +1153.97% |
| 2007-12-31 | $48.85 Million | $574.57K | 0.012x | +112.79% |
| 2006-12-31 | $47.97 Million | $-4.41 Million | -0.092x | -273.93% |
| 2005-12-31 | $52.73 Million | $-1.30 Million | -0.025x | +28.16% |
| 2004-12-31 | $56.97 Million | $-1.95 Million | -0.034x | +64.87% |
| 2003-12-31 | $47.90 Million | $-4.67 Million | -0.097x | +7.33% |
| 2002-12-31 | $21.46 Million | $-2.26 Million | -0.105x | +84.43% |
| 2001-12-31 | $2.04 Million | $-1.38 Million | -0.675x | -241.10% |
| 2000-12-31 | $2.90 Million | $-574.33K | -0.198x | +40.63% |
| 1999-12-31 | $3.00 Million | $-1.00 Million | -0.333x | +63.49% |
| 1998-12-31 | $2.30 Million | $-2.10 Million | -0.913x | -172.19% |
| 1997-12-31 | $3.40 Million | $4.30 Million | 1.265x | +618.53% |
| 1996-12-31 | $4.10 Million | $-1.00 Million | -0.244x | -72.76% |
| 1995-12-31 | $8.50 Million | $-1.20 Million | -0.141x | -374.29% |
| 1994-12-31 | $13.60 Million | $700.00K | 0.051x | -85.38% |
| 1993-12-31 | $12.50 Million | $4.40 Million | 0.352x | +396.71% |
| 1992-12-31 | $12.70 Million | $900.00K | 0.071x | +216.22% |
| 1991-12-31 | $8.20 Million | $-500.00K | -0.061x | +83.36% |
| 1990-12-31 | $13.10 Million | $-4.80 Million | -0.366x | -131.81% |
| 1988-12-31 | $7.90 Million | $9.10 Million | 1.152x | -- |
About icad inc
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurat… Read more